Edward Morrow Atkinson III - Mar 1, 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Edward Morrow Atkinson III
Stock symbol
ETNB
Transactions as of
Mar 1, 2023
Transactions value $
-$91,600
Form type
4
Date filed
3/3/2023, 04:18 PM
Previous filing
Feb 13, 2023
Next filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Options Exercise $44.4K +10K $4.44 10K Mar 1, 2023 Direct
transaction ETNB Common Stock Sale -$136K -10K -100% $13.60 0 Mar 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -10K -33.33% $0.00 20K Mar 1, 2023 Common Stock 10K $4.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $13.49 to $14.83. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, which vests in equal installments on February 17, 2023, February 17, 2024 and February 17, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.